MedTrace Logo

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP

NCT04442087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 563

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to define seroprevalence of anti-SARS-CoV2 among children of Hospital Workers in APHP, particularly exposed population, according to parents' SARS-CoV2 serological status.

Conditions

  • SARS-CoV2

Interventions

BIOLOGICAL

Serology SARS-CoV2

Collect serum for Serology SARS-CoV2 at inclusion

BEHAVIORAL

Data collection

Collect clinical and demographic data, habitus, Lifestyle Counseling at inclusion

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Solen KERNEIS, MD · Assistance Publique - Hôpitaux de Paris

  • Flore ROZENBERG, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Jean-Marc TRELUYER, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442087 on ClinicalTrials.gov